Riley Bove, MD

Title(s)Associate Professor, Neurology
SchoolSchool of Medicine
Pronounsshe/her/hers
ORCID ORCID Icon0000-0002-2034-8800 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeA.B.1998Biological Anthropology
    Harvard Medical SchoolM.D.2007
    Harvard Medical SchoolM.M.Sc.2014
    University of California, San Francisco01/2022Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Dr. Riley Bove is a practicing neurologist and clinician scientist in the UCSF Weill Institute for Neurosciences.

    Dr. Bove is a national and international leader in sex and gender aspects of Neurology, publishing, collaborating and lecturing widely on this topic. She is PI of the first industry-sponsored Phase IV trial of a medication for use in pregnant and lactating people with MS and led the first RCT in menopausal women with MS. She is founding Director of the SAGE Neurology Program at UCSF, whose educational mission is supported by an NINDS R25 training grant. In the technology space, Dr. Bove has conducted innovative work designing, validating and implementing digital tools to improve care access, holistic measures of patient function, and as digital therapeutics. She is co-PI of the BRIDGE precision medicine dashboards that support delivery of point-of-care personalized medicine.

    Dr. Bove graduated Phi Beta Kappa in anthropology from Harvard College, then conducted ethnographic study and film work on a Fulbright grant, learning from patients and families. She received her MD and MMSc from Harvard Medical School. She completed a neurology residency in the Massachusetts General/Brigham Hospitals program, followed by a clinical research fellowship at the Partners MS Center. Dr. Bove serves on the Science Committee of the American Academy of Neurology and is on the Editorial Board of Annals of Neurology and Neurology N2. Her research is supported by the NIH, Department of Defense, National MS Society, foundations and industry sources. She is committed to training the next generation of clinicians and scientists, and mentors students, doctoral and postdoctoral trainees in a variety of individualized clinical and training plans. Dr. Bove contributes to global neurology and equity initiatives through the Global Teleneurology Service and the BALANCE program.

    Dr. Bove sees patients in the UCSF Multiple Sclerosis and Neuroinflammation Center where she provides comprehensive care for individuals with MS that is informed by their sex, gender, reproductive goals, and more broadly, by their life phase and goals. She speaks French and Spanish.
    Collapse Websites
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Sex and Gender Enriched Neurology
    NIH/NINDS R25NS136037Sep 1, 2023 - Aug 31, 2027
    Role: Principal Investigator
    Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
    NIH/NINR R01NR020323Sep 26, 2022 - Jun 30, 2027
    Role: Co-Investigator
    MS CATCH: Closing the Gaps in Depression Care for People with MS By Closing the Information Loop
    Department of Defense W81XWH2210894Aug 15, 2022 - Aug 14, 2025
    Role: Principal Investigator
    Description: The goal of this study is to evaluate the effect of a comprehensive, closed-loop, digital health platform (MS CATCH) on depression care in adults with MS.
    MS Falls InsightTrack (MS FIT): A personal health library to reduce falls in patients with MS
    NIH R01LM013396Sep 1, 2021 - May 31, 2025
    Role: Principal Investigator
    Trials for remyelination in MS: From bench to bedside to home.
    National Multiple Sclerosis Society Harry Weaver Neuroscience AwardJul 1, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Trials for remyelination in MS: From bench to bedside to home.
    National Multiple Sclerosis Society Harry Weaver Neuroscience AwardJul 1, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Career Transition Award
    National Multiple Sclerosis Society Jul 1, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Training Grant in Systemic Autoimmunity
    NIH T32AI074549Aug 1, 2008 - Jul 31, 2019
    Role: Trainee
    Hormones and Genes in Women's Health: Bench to Bedside
    NIH K12HD051959Sep 1, 2005 - Jul 31, 2020
    Role: Trainee 2013-2014

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Low Referral Rates for Pelvic Floor Physical Therapy in MS Patients with Bladder Dysfunction: An Opportunity to Close the Gap. Multiple Sclerosis and Related Disorders. 2024 Jun 1; 86:105592. Winawer WI, Bove BR, Keyan KZ, Cree CB, Gelfand GJ, Block BV. .
      View in: Publisher Site   Mentions:
    2. WeB: A Pilot Study of WEarables for Bladder Monitoring in People with Multiple Sclerosis (S7.009). Neurology. 2024 Apr 9; 102(17_supplement_1). Block BV, Suskind SA, Guo GC, Poole PS, Cutter CG, Bove BR. .
      View in: Publisher Site   Mentions:
    3. Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study (P4-6.014). Neurology. 2024 Apr 9; 102(17_supplement_1). Rose RM, Hsu HS, Balan BA, Anderson AA, Houtchens HM, Bove BR. .
      View in: Publisher Site   Mentions:
    4. Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort (P10-14.010). Neurology. 2024 Apr 9; 102(17_supplement_1). Zuroff ZL, Wijangco WJ, Brandstadter BR, Goldman GM, Graham GE, Farber FR, Valizadeh VN, Freeman FL, Cree CB, Bove BR, Jacobs JD. .
      View in: Publisher Site   Mentions:
    5. Digital Facial Analysis Correlates with Mood and Cognitive Outcomes with People with MS (P6-6.013). Neurology. 2024 Apr 9; 102(17_supplement_1). Nylander NA, Henderson HK, Koshal KK, Sisodia SN, Wijangco WJ, Poole PS, Rowson RJ, Halabi HC, Brown BE, Possin PK, Staffaroni SA, Bove BR. .
      View in: Publisher Site   Mentions:
    6. Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004). Neurology. 2024 Apr 9; 102(17_supplement_1). Bove BR, Pietrasanta PC, Oreja-Guevara OC, Hellwig HK, Dobson DR, Vukusic VS, Lin LC, Alvarez AD, Zecevic ZD, Ferreira FG, Craveiro CL, Pasquarelli PN, McElrath MT. .
      View in: Publisher Site   Mentions:
    7. Attention to Sex as a Biological Variable in Phase III Neurological Trials Before and After the 2017 NIH Amendment: a Systematic Review in MS (P4-6.001). Neurology. 2024 Apr 9; 102(17_supplement_1). Balan BA, Bove BR, Sormani SM, Houtchens HM. .
      View in: Publisher Site   Mentions:
    8. Face Validity: Digital Facial Analysis Recapitulates Clinical Findings of Neurological Disease (P10-4.002). Neurology. 2024 Apr 9; 102(17_supplement_1). Nylander NA, Henderson HK, Koshal KK, Sisodia SN, Wijangco WJ, Poole PS, Rowson RJ, Halabi HC, Ostrem OJ, Little LS, Brown BE, Staffaroni SA, Bove BR. .
      View in: Publisher Site   Mentions:
    9. Données de grossesses et des enfants de femmes recevant ocrelizumab pour le traitement de la sclérose en plaques : analyse de la plus grande base de données disponible. Revue Neurologique. 2024 Apr 1; 180:s136. Vukusic VS, Hellwig HK, Oreja-Guevara OC, Pietrasanta PC, McElrath MT, Dobson DR, Bove BR. .
      View in: Publisher Site   Mentions:
    10. A Closed-Loop Digital Health Tool to Improve Depression Care in Multiple Sclerosis: Iterative Design and Cross-Sectional Pilot Randomized Controlled Trial and its Impact on Depression Care. JMIR Form Res. 2024 Mar 15; 8:e52809. Henderson K, Reihm J, Koshal K, Wijangco J, Sara N, Miller N, Doyle M, Mallory A, Sheridan J, Guo CY, Oommen L, Rankin KP, Sanders S, Feinstein A, Mangurian C, Bove R. PMID: 38488827.
      View in: PubMed   Mentions:
    11. Expert opinion on the use of contraception in people with multiple sclerosis. Mult Scler. 2024 Mar 08; 13524585241228103. Hillert J, Bove R, Haddad LB, Hellwig K, Houtchens M, Magyari M, Merki-Feld GS, Montgomery S, Nappi RE, Stenager E, Thompson H, Tulek Z, Verdun Di Cantogno E, Simoni M. PMID: 38456514.
      View in: PubMed   Mentions:    Fields:    
    12. The postmenopausal brain: no silver bullet, but silver linings. Lancet Neurol. 2024 Mar; 23(3):238-239. Bove R, Silverman H, Valeggia C. PMID: 38365376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Cognitive function influences cognitive-motor interference during dual task walking in multiple sclerosis. Mult Scler Relat Disord. 2024 Feb 29; 85:105516. Hsu WY, Block VJ, Wijangco J, Henderson K, Nylander A, Koshal K, Poole S, Possin KL, Staffaroni AM, Bove RM. PMID: 38461729.
      View in: PubMed   Mentions:    Fields:    
    14. Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS CATCH study protocol. BMJ Open. 2024 Feb 24; 14(2):e077432. Henderson K, Reihm J, Koshal K, Wijangco J, Miller N, Sara N, Doyle M, Mallory A, Sheridan J, Guo CY, Oommen L, Feinstein A, Mangurian C, Lazar A, Bove R. PMID: 38401894; PMCID: PMC10895222.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    15. Leveraging electronic health records and knowledge networks for Alzheimer's disease prediction and sex-specific biological insights. Nat Aging. 2024 Mar; 4(3):379-395. Tang AS, Rankin KP, Cerono G, Miramontes S, Mills H, Roger J, Zeng B, Nelson C, Soman K, Woldemariam S, Li Y, Lee A, Bove R, Glymour M, Aghaeepour N, Oskotsky TT, Miller Z, Allen IE, Sanders SJ, Baranzini S, Sirota M. PMID: 38383858; PMCID: PMC10950787.
      View in: PubMed   Mentions: Translation:Humans
    16. Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths. Neurol Clin Pract. 2024 Apr; 14(2):e200253. Graham EL, Bove R, Costello K, Crayton H, Jacobs DA, Shah S, Sorrell F, Stoll SS, Houtchens MK. PMID: 38585436; PMCID: PMC10996912.
      View in: PubMed   Mentions:
    17. Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort Neurology. 2024 02 27; 102(4):e208100. Radzik AM, Amezcua L, Anderson A, Gilmore S, Ahmad S, Brandstadter R, Fabian MT, Graham EL, Hodgkinson S, Horton L, Jacobs DA, Katz Sand IB, Kohli A, Levine L, McLemore M, Okai AF, Patel J, Poole S, Riley C, Satyanarayan S, Tardo L, Verter E, Villacorta V, Zimmerman V, Zuroff L, Williams MJ, Houtchens MK, Bove R. PMID: 38261988; PMCID: PMC10962915.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrack. JMIR Hum Factors. 2024 Jan 11; 11:e49331. Block VJ, Koshal K, Wijangco J, Miller N, Sara N, Henderson K, Reihm J, Gopal A, Mohan SD, Gelfand JM, Guo CY, Oommen L, Nylander A, Rowson JA, Brown E, Sanders S, Rankin K, Lyles CR, Sim I, Bove R. PMID: 38206662; PMCID: PMC10811573.
      View in: PubMed   Mentions: 2  Translation:Humans
    19. Emerging Subspecialties in Neurology: Women's Neurology. Neurology. 2024 Jan 9; 102(1). Thornton TH, LaHue LS, Bove BR, Waters WJ, O'Neal OM, Bui BE. .
      View in: Publisher Site   Mentions:
    20. Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study. Sci Rep. 2024 01 02; 14(1):122. Oh J, Capezzuto L, Kriara L, Schjodt-Eriksen J, van Beek J, Bernasconi C, Montalban X, Butzkueven H, Kappos L, Giovannoni G, Bove R, Julian L, Baker M, Gossens C, Lindemann M. PMID: 38168498; PMCID: PMC10762023.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis. JAMA Neurol. 2024 Jan 01; 81(1):85-87. Kim J, Kesselheim AS, Bove R, Avorn J, Rome BN. PMID: 38010690; PMCID: PMC10682942.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Multiple Sclerosis and Family Planning: A Survey Study of the Patient Experience. Neurol Clin Pract. 2024 Feb; 14(1):e200222. Kelly EE, Engel C, Pearsall R, Brenton JN, Bove R, Oh U, Goldman MD. PMID: 38148835; PMCID: PMC10751018.
      View in: PubMed   Mentions:
    23. Hormonal Therapies in Multiple Sclerosis: a Review of Clinical Data. Curr Neurol Neurosci Rep. 2024 Jan; 24(1):1-15. Hsu S, Bove R. PMID: 38102502; PMCID: PMC10774191.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Emerging Subspecialties in Neurology: Women's Neurology. Neurology. 2024 Jan 09; 102(1):e208009. Thornton HF, LaHue SC, Bove R, Waters J, O'Neal MA, Bui E. PMID: 38165380; PMCID: PMC10834140.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database. Multiple Sclerosis and Related Disorders. 2023 Dec 1; 80:105306. Hellwig HK, Oreja-Guevara OC, Vukusic VS, Pietrasanta PC, Mcelrath MT, Dobson DR, Craveiro CL, Ferreira FG, Lin LC, Pasquarelli PN, Zecevic ZD, Bove BR. .
      View in: Publisher Site   Mentions:
    26. "Self-care selfies": Patient-uploaded videos capture meaningful changes in dexterity over 6 months. Ann Clin Transl Neurol. 2023 12; 10(12):2394-2406. Gopal A, Torres WO, Winawer I, Poole S, Balan A, Stuart HS, Fritz NE, Gelfand JM, Allen DD, Bove R. PMID: 37877622; PMCID: PMC10723247.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Effects of transcranial alternating current stimulation on cognitive function in people with multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord. 2023 Dec; 80:105090. Hsu WY, Zanto T, Park JE, Gazzaley A, Bove RM. PMID: 37925960.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis. Contemp Clin Trials. 2023 Nov; 134:107333. Nylander A, Anderson A, Rowles W, Hsu S, Lazar AA, Mayoral SR, Pease-Raissi SE, Green A, Bove R. PMID: 37739167.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    29. Well-being at midlife: Correlates of mental health in ambulatory menopausal women with multiple sclerosis. Mult Scler. 2023 10; 29(11-12):1493-1502. Morales-Rodriguez D, Anderson A, Nylander A, Hsu S, Singh J, Rowles W, Walsh CM, Braley TJ, Bove R. PMID: 37715710; PMCID: PMC10580672.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Fall Assessment and Monitoring in People With Multiple Sclerosis: A Practical Evidence-Based Review for Clinicians. Neurol Clin Pract. 2023 Oct; 13(5):e200184. Gopal A, Gelfand JM, Bove R, Block VJ. PMID: 37720138; PMCID: PMC10503932.
      View in: PubMed   Mentions: 1  
    31. Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions. Ann Clin Transl Neurol. 2023 11; 10(11):2053-2064. Anderson A, Rowles W, Poole S, Balan A, Bevan C, Brandstadter R, Ciplea AI, Cooper J, Fabian M, Hale TW, Jacobs D, Kakara M, Krysko KM, Longbrake EE, Marcus J, Repovic P, Riley CS, Romeo AR, Rutatangwa A, West T, Hellwig K, LaHue SC, Bove R. PMID: 37675826; PMCID: PMC10647007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Women's Health and Pregnancy in Multiple Sclerosis. Neurol Clin. 2024 Feb; 42(1):275-293. Bove R, Sutton P, Nicholas J. PMID: 37980119.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Characteristics of multiple sclerosis and demyelinating disease in an Asian American population. Mult Scler. 2023 09; 29(10):1216-1228. Fan JH, Alexander J, Poole S, Wijangco J, Henson LJ, Dobson R, Guo CY, Bove R. PMID: 37548214.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Women’s Health and Pregnancy in Multiple Sclerosis. Neurologic Clinics. 2023 Aug 1. Bove BR, Sutton SP, Nicholas NJ. .
      View in: Publisher Site   Mentions:
    35. Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis. medRxiv. 2023 Jul 03. Chitnis T, Qureshi F, Gehman VM, Becich M, Bove R, Cree BAC, Gomez R, Hauser SL, Henry RG, Katrib A, Lokhande H, Paul A, Caillier SJ, Santaniello A, Sattarnezhad N, Saxena S, Weiner H, Yano H, Baranzini SE. PMID: 37461671; PMCID: PMC10350151.
      View in: PubMed   Mentions:
    36. Influence of menstrual cycle and hormonal contraceptive use on MS symptom fluctuations: A pilot study. Mult Scler Relat Disord. 2023 Sep; 77:104864. Taylor H, Alhasan S, Saleem M, Poole S, Jiang F, Longbrake EE, Bove R. PMID: 37480738.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Clinical course of multiple sclerosis and patient experiences during breast cancer treatment. Mult Scler. 2023 07; 29(8):967-978. Nylander AN, Singh J, Poole S, Anderson A, Marrie RA, Rugo H, Bove R. PMID: 37291903; PMCID: PMC10338705.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Designing a Closed-loop Falls Monitoring and Prevention Application for Multiple Sclerosis Clinical Practice: The MS Falls InsightTrack (MS FIT) (Preprint). JMIR Human Factors. 2023 May 26. Block BV, Koshal KK, Wijangco WJ, Miller MN, Sara SN, Henderson HK, Reihm RJ, Gopal GA, Mohan MS, Gelfand GJ, Glassel GL, Guo GC, Oommen OL, Nylander NA, Rowson RJ, Brown BE, Sanders SS, Rankin RK, Lyles LC, Sim SI, Bove BR. .
      View in: Publisher Site   Mentions:
    39. A Predictive Autoantibody Signature in Multiple Sclerosis. medRxiv. 2023 May 15. Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, Jabassini N, Mann SA, Ragan NR, Santaniello A, Henry RG, Baranzini SE, Zamvil SS, Bove RM, Guo CY, Gelfand JM, Cuneo R, von Büdingen HC, Oksenberg JR, Cree BA, Hollenbach JA, Green AJ, Hauser SL, Wallin MT, DeRisi JL, Wilson MR. PMID: 37205595; PMCID: PMC10187343.
      View in: PubMed   Mentions:
    40. Spatio-Temporal Gait Parameters to Distinguish Multiple Sclerosis Disability during Dual- Task Walk. Multiple Sclerosis and Related Disorders. 2023 May 1; 73:104637. Stucke SM, Schoell SM, Torrecampo TD, In IK, DePaoli DJ, Wijangco WJ, Henderson HK, Koshal KK, Poole PS, Block BV, Bove BR. .
      View in: Publisher Site   Mentions:
    41. Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses. J Neurol Neurosurg Psychiatry. 2023 11; 94(11):934-937. Novak F, Bajwa HM, Coia JE, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Hvidt MVM, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. PMID: 37185261; PMCID: PMC10579504.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    42. Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database (P9-3.014). Neurology. 2023 Apr 25; 100(17_supplement_2). Bove BR, Amato AM, Dobson DR, Krysko KK, Stoll SS, Vukusic VS, Yamout YB, Zielman ZR, Gummuluri GS, Jehl JV, Topphoff TU, Sullivan SR, Fantaccini FS, Hellwig HK. .
      View in: Publisher Site   Mentions:
    43. Accelerated Worsening in Serum Neurofilament Light Chain Levels and Multiple Sclerosis Functional Composite in Women with MS after Menopause (S9.009). Neurology. 2023 Apr 25; 100(17_supplement_2). Silverman SH, Bostrom BA, Lazar LA, Gomez GR, Santaniello SA, Renschen RA, Harms HM, Cooper CT, Lincoln LR, Poole PS, Henry HR, Oksenberg OJ, Hauser HS, Cree CB, Bove BR. .
      View in: Publisher Site   Mentions:
    44. Données de grossesses et des enfants de femmes recevant ocrélizumab pour le traitement de la sclérose en plaques. Revue Neurologique. 2023 Apr 1; 179:s153. Oreja-Guevara OC, Vukusic VS, Pietrasanta PC, Mcelrath MT, Hellwig HK, Bove BR, Dobson DR. .
      View in: Publisher Site   Mentions:
    45. Family planning considerations in people with multiple sclerosis. Lancet Neurol. 2023 04; 22(4):350-366. Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M, Jokubaitis VG, Magyari M, Abdelnasser A, Padma V, Thiel S, Tintore M, Vukusic S, Hellwig K. PMID: 36931808.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    46. A virtual reality program to assess cognitive function in multiple sclerosis: A pilot study. Front Hum Neurosci. 2023; 17:1139316. Hsu WY, Anguera JA, Rizzo A, Campusano R, Chiaravalloti ND, DeLuca J, Gazzaley A, Bove RM. PMID: 37007676; PMCID: PMC10060881.
      View in: PubMed   Mentions:
    47. Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era. Neurol Neuroimmunol Neuroinflamm. 2023 05; 10(3). Graham EL, Bakkensen JB, Anderson A, Lancki N, Davidson A, Perez Giraldo G, Jungheim ES, Vanderhoff AC, Ostrem B, Mok-Lin E, Huang D, Bevan CJ, Jacobs D, Kaplan TB, Houtchens MK, Bove R. PMID: 36922025; PMCID: PMC10018493.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    48. Remote Observational Research for Multiple Sclerosis: A Natural Experiment. Neurol Neuroimmunol Neuroinflamm. 2023 03; 10(2). Bove R, Poole S, Cuneo R, Gupta S, Sabatino J, Harms M, Cooper T, Rowles W, Miller N, Gomez R, Lincoln R, McPolin K, Powers K, Santaniello A, Renschen A, Bevan CJ, Gelfand JM, Goodin DS, Guo CY, Romeo AR, Hauser SL, Campbell Cree BA, UCSF MS-EPIC Team. PMID: 36585249; PMCID: PMC9808915.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    49. Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators. Mult Scler Relat Disord. 2023 Feb; 70:104484. Sabatino JJ, Mittl K, Rowles W, Zamecnik CR, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Alexander J, Mcpolin K, Chen P, Deshpande C, Wyse K, Maiese EM, Wilson MR, Zamvil SS, Bove R. PMID: 36608538; PMCID: PMC9794398.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    50. Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis. Mult Scler. 2023 03; 29(3):363-373. Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG. PMID: 36573559; PMCID: PMC9972237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Capturing cognitive changes in multiple sclerosis by performance-based functional and virtual reality assessments. Ann Phys Rehabil Med. 2023 Apr; 66(3):101677. Hsu WY, Goverover Y, Bove RM. PMID: 35667625.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Clinical and Research Applications of the Electronic Medical Record in Multiple Sclerosis: A Narrative Review of Current Uses and Future Applications. Int J MS Care. 2022 Nov-Dec; 24(6):287-294. Swetlik C, Bove R, McGinley M. PMID: 36545651; PMCID: PMC9749832.
      View in: PubMed   Mentions: 1  
    53. Reproductive Rights in Neurology-The Supreme Court's Impact on All of Us. JAMA Neurol. 2022 10 01; 79(10):961-962. LaHue SC, Gano D, Bove R. PMID: 35830178; PMCID: PMC9561053.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. USE OF ASSISTED REPRODUCTIVE TECHNOLOGIES DOES NOT INCREASE RISK OF RELAPSE AMONG WOMEN WITH MULTIPLE SCLEROSIS: A MULTICENTER COHORT STUDY. Fertility and Sterility. 2022 Oct 1; 118(4):e285. Bakkensen BJ, Graham GE, Vanderhoff VA, Lancki LN, Anderson AA, Ostrem OB, Perez PG, Jacobs JD, Houtchens HM, Kaplan KT, Bove BR, Jungheim JE. .
      View in: Publisher Site   Mentions:
    55. Challenges in the Clinical Recognition of Acute Flaccid Myelitis and its Implications. J Pediatr. 2023 02; 253:55-62.e4. Hayes LH, Hopkins SE, Liu S, Pardo CA, Garcia-Dominguez MA, Oleszek J, Yea C, Ciftci-Kavaklioglu B, Yeh EA, Dean J, Sadowsky CL, Desai J, Wiegand S, Farias-Moeller R, Nash K, Thakur KT, Vargas WS, Hong-Routson SJ, Yeshokumar A, Zhou MS, Makhani N, Wilson-Murphy M, Bove R, Zhang B, Benson LA. PMID: 36115622.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Accessibility to Telerehabilitation Services for People With Multiple Sclerosis: Analysis of Barriers and Limitations. Int J MS Care. 2022 Nov-Dec; 24(6):260-265. Gopal A, Bonanno V, Block VJ, Bove RM. PMID: 36545648; PMCID: PMC9749830.
      View in: PubMed   Mentions: 1  
    57. IVF and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk. Neurology. 2022 Aug 11. Dobson R, Bove R. PMID: 35953290.
      View in: PubMed   Mentions:    Fields:    
    58. In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk. Neurology. 2022 10 25; 99(17):737-738. Dobson R, Bove R. PMID: 36280278.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Improving the Automatic Classification of Brain MRI Acquisition Contrast with Machine Learning. J Digit Imaging. 2023 02; 36(1):289-305. Cluceru J, Lupo JM, Interian Y, Bove R, Crane JC. PMID: 35941406; PMCID: PMC9984597.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. The Role of Remote Monitoring in Evaluating Fatigue in Multiple Sclerosis: A Review. Front Neurol. 2022; 13:878313. Block VJ, Bove R, Nourbakhsh B. PMID: 35832181; PMCID: PMC9272225.
      View in: PubMed   Mentions: 4  
    61. Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. Mult Scler J Exp Transl Clin. 2022 Apr-Jun; 8(2):20552173221104918. Ostrem BL, Anderson A, Conway S, Healy BC, Oh J, Jacobs D, Dobson R, Graham EL, Sadovnick AD, Zimmerman V, Liu Y, Bove R, Houtchens M. PMID: 35734229; PMCID: PMC9208060.
      View in: PubMed   Mentions: 1  
    62. Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants. Mult Scler Relat Disord. 2022 Aug; 64:103963. Bove R, Hellwig K, Pasquarelli N, Borriello F, Dobson R, Oreja-Guevara C, Lin CJ, Zecevic D, Craveiro L, McElrath T, Vukusic S. PMID: 35753176.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Making Every Step Count: Minute-by-Minute Characterization of Step Counts Augments Remote Activity Monitoring in People With Multiple Sclerosis. Front Neurol. 2022; 13:860008. Block VJ, Waliman M, Xie Z, Akula A, Bove R, Pletcher MJ, Marcus GM, Olgin JE, Cree BAC, Gelfand JM, Henry RG. PMID: 35677343; PMCID: PMC9167929.
      View in: PubMed   Mentions: 1  
    64. Nocturnal Hypoventilation as a Respiratory Complication of Acute Flaccid Myelitis. J Pediatr. 2022 09; 248:122-125. Aziz-Bose R, Bhargava S, Buu M, Bove R, van Haren K. PMID: 35605645.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    65. Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data. Neurol Neuroimmunol Neuroinflamm. 2022 07; 9(4). Rowles WM, Hsu WY, McPolin K, Li A, Merrill S, Guo CY, Green AJ, Gelfand JM, Bove RM. PMID: 35581005; PMCID: PMC9128034.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform. JMIR Hum Factors. 2022 May 06; 9(2):e33967. Brown EG, Schleimer E, Bledsoe IO, Rowles W, Miller NA, Sanders SJ, Rankin KP, Ostrem JL, Tanner CM, Bove R. PMID: 35522472; PMCID: PMC9123539.
      View in: PubMed   Mentions: 1  
    67. Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab (P4-4.007). Neurology. 2022 May 3; 98(18_supplement). Hellwig HK, Yamout YB, Bove BR, Katkuri KP, Topphoff TU, Stoneman SD, Zielman ZR, Pingili PR, Houtchens HM. .
      View in: Publisher Site   Mentions:
    68. Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis. Mult Scler Relat Disord. 2022 Jun; 62:103793. Kaplan TB, Gopal A, Block VJ, Suskind AM, Zhao C, Polgar-Turcsanyi M, Saraceno TJ, Gomez R, Santaniello A, Consortium S, Ayoubi NE, Cree BAC, Hauser SL, Weiner H, Chitnis T, Khoury S, Bove R. PMID: 35461057.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Use of B-Cell-Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Neurol Clin Pract. 2022 Apr; 12(2):154-163. Galati A, McElrath T, Bove R. PMID: 35733945; PMCID: PMC9208398.
      View in: PubMed   Mentions: 6  
    70. Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques. Revue Neurologique. 2022 Apr 1; 178:s112. Vukusic VS, Dobson DR, Bove BR, Hellwig HK, Pasquarelli PN, Zecevic ZD, Oreja-Guevara OC. .
      View in: Publisher Site   Mentions:
    71. A Biomedical Open Knowledge Network Harnesses the Power of AI to Understand Deep Human Biology. AI Magazine. 2022 Mar 31; 43(1):46-58. Baranzini BS, Börner BK, Morris MJ, Nelson NC, Soman SK, Schleimer SE, Keiser KM, Musen MM, Pearce PR, Reza RT, Smith SB, Herr II HB, Oskotsky OB, Rizk-Jackson RA, Rankin RK, Sanders SS, Bove BR, Rose RP, Israni IS, Huang HS. .
      View in: Publisher Site   Mentions:
    72. Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS". Ann Neurol. 2022 05; 91(5):735-736. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BA, Hauser SL, Henry RG. PMID: 35233827; PMCID: PMC9511767.
      View in: PubMed   Mentions:    Fields:    
    73. A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial. Mult Scler Relat Disord. 2022 May; 61:103747. Bove R, Anderson A, Rowles W, Rankin KA, Hills NK, Carleton M, Cooper J, Cree BAC, Gelfand JM, Graves JS, Henry RG, Krysko KM, Rush G, Zamvil SS, Joffe H, Chan JR, Green AJ. PMID: 35397292.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    74. Remote Assessments of Hand Function in Neurological Disorders: Systematic Review. JMIR Rehabil Assist Technol. 2022 Mar 09; 9(1):e33157. Gopal A, Hsu WY, Allen DD, Bove R. PMID: 35262502; PMCID: PMC8943610.
      View in: PubMed   Mentions: 4  
    75. Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients. Mult Scler Relat Disord. 2022 Apr; 60:103729. Bajwa HM, Novak F, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Witt AH, Byg KE, Johansen IS, Mittl K, Rowles W, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. PMID: 35334278; PMCID: PMC8898195.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    76. Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab. Multiple Sclerosis and Related Disorders. 2022 Mar 1; 59:103632. Yamout YB, Hellwig HK, Bove BR, Katkuri KP, Topphoff TU, Stoneman SD, Zielman ZR, Pingili PR, Houtchens HM. .
      View in: Publisher Site   Mentions:
    77. Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function. JCI Insight. 2022 02 22; 7(4). Sabatino JJ, Mittl K, Rowles WM, McPolin K, Rajan JV, Laurie MT, Zamecnik CR, Dandekar R, Alvarenga BD, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Augusto DG, Alexander JR, DeRisi JL, Hollenbach JA, Wilson MR, Zamvil SS, Bove R. PMID: 35030101; PMCID: PMC8876469.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    78. Building a Precision Medicine Delivery Platform for Clinics: The University of California, San Francisco, BRIDGE Experience. J Med Internet Res. 2022 02 15; 24(2):e34560. Bove R, Schleimer E, Sukhanov P, Gilson M, Law SM, Barnecut A, Miller BL, Hauser SL, Sanders SJ, Rankin KP. PMID: 35166689; PMCID: PMC8889486.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    79. Standardized Integration of Person-Generated Data Into Routine Clinical Care. JMIR Mhealth Uhealth. 2022 02 10; 10(2):e31048. Zeng B, Bove R, Carini S, Lee JS, Pollak JP, Schleimer E, Sim I. PMID: 35142627; PMCID: PMC8874926.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Pregnancy Management in Multiple Sclerosis and Other Demyelinating Diseases. Continuum (Minneap Minn). 2022 02 01; 28(1):12-33. Bove RM, Houtchens MK. PMID: 35133309.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. Embedding electronic health records onto a knowledge network recognizes prodromal features of multiple sclerosis and predicts diagnosis. J Am Med Inform Assoc. 2022 01 29; 29(3):424-434. Nelson CA, Bove R, Butte AJ, Baranzini SE. PMID: 34915552; PMCID: PMC8800523.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    82. Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis. Ann Neurol. 2022 02; 91(2):268-281. Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono J, Bevan CJ, Bove RM, Crabtree E, Gelfand JM, Goodin DS, Graves JS, Green AJ, Oksenberg JR, Waubant E, Wilson MR, Zamvil SS, University of California, San Francisco MS-EPIC Team, Cree BAC, Hauser SL, Henry RG. PMID: 34878197; PMCID: PMC8916838.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    83. Assessing Cognitive Function in Multiple Sclerosis With Digital Tools: Observational Study. J Med Internet Res. 2021 12 30; 23(12):e25748. Hsu WY, Rowles W, Anguera JA, Anderson A, Younger JW, Friedman S, Gazzaley A, Bove R. PMID: 34967751; PMCID: PMC8759021.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study. Mult Scler J Exp Transl Clin. 2021 Oct; 7(4):20552173211048756. Hsu WY, Anderson A, Rowles W, Peters KE, Li V, Stone KL, Ashbrook LH, Gelfand AA, Bove RM. PMID: 34777854; PMCID: PMC8573503.
      View in: PubMed   Mentions: 4  
    85. Building a precision medicine delivery platform for the clinic: the UCSF BRIDGE experience. (Preprint). Journal of Medical Internet Research. 2021 Oct 29. Bove BR, Schleimer SE, Sukhanov SP, Gilson GM, Law LS, Barnecut BA, Miller MB, Hauser HS, Sanders SS, Rankin RK. .
      View in: Publisher Site   Mentions:
    86. Experiences of sexual and gender minority people living with multiple sclerosis in Northern California: An exploratory study. Multiple Sclerosis and Related Disorders. 2021 Oct 1; 55:103214. Anderson AA, Dierkhising DJ, Rush RG, Carleton CM, Rosendale RN, Bove BR. .
      View in: Publisher Site   Mentions:
    87. Glucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist. J Neurol Sci. 2021 Nov 15; 430:120004. Galati A, Brown ES, Bove R, Vaidya A, Gelfand J. PMID: 34598056.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity. medRxiv. 2021 Sep 20. Sabatino JJ, Mittl K, Rowles W, Mcpolin K, Rajan JV, Zamecnik CR, Dandekar R, Alvarenga BD, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Augusto DG, Alexander J, Hollenbach JA, Wilson MR, Zamvil SS, Bove R. PMID: 34580672; PMCID: PMC8475959.
      View in: PubMed   Mentions:
    89. Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis. Mult Scler Relat Disord. 2021 Nov; 56:103251. Novak F, Nilsson AC, Nielsen C, Holm DK, Østergaard K, Bystrup A, Byg KE, Johansen IS, Mittl K, Rowles W, Mcpolin K, Spencer C, Sagan S, Gerungan C, Wilson MR, Zamvil SS, Bove R, Sabatino JJ, Sejbaek T. PMID: 34571415; PMCID: PMC8426319.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsPHPublic Health
    90. Risk factors for peripartum depression in women with multiple sclerosis. Mult Scler. 2022 05; 28(6):970-979. Krysko KM, Anderson A, Singh J, McPolin K, Rutatangwa A, Rowles W, Sadovnick AD, Houtchens MK, Bove R. PMID: 34498513.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    91. Identifying falls remotely in people with multiple sclerosis. J Neurol. 2022 Apr; 269(4):1889-1898. Block VJ, Pitsch EA, Gopal A, Zhao C, Pletcher MJ, Marcus GM, Olgin JE, Hollenbach J, Bove R, Cree BAC, Gelfand JM. PMID: 34405267; PMCID: PMC8370664.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    92. Experiences of sexual and gender minority people living with multiple sclerosis in Northern California: An exploratory study. Mult Scler Relat Disord. 2021 Oct; 55:103214. Anderson A, Dierkhising J, Rush G, Carleton M, Rosendale N, Bove R. PMID: 34428637.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    93. Electronic Health Record Technology Designed for the Clinical Encounter: MS NeuroShare. Neurol Clin Pract. 2021 Aug; 11(4):318-326. Bove R, Bruce CA, Lunders CK, Pearce JR, Liu J, Schleimer E, Hauser SL, Stewart WF, Jones JB. PMID: 34484932; PMCID: PMC8382438.
      View in: PubMed   Mentions: 7  
    94. Standardized Integration of Person-Generated Data into Routine Clinical Care (Preprint). JMIR mHealth and uHealth. 2021 Jun 7. Bove BR, Schleimer SE, Sim SI. .
      View in: Publisher Site   Mentions:
    95. American Academy of Neurology Telehealth Position Statement. Neurology. 2021 08 17; 97(7):334-339. Hatcher-Martin JM, Busis NA, Cohen BH, Wolf RA, Jones EC, Anderson ER, Fritz JV, Shook SJ, Bove RM. PMID: 33986141; PMCID: PMC8377877.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    96. Traitement de la sclérose en plaques (SEP) par ocrelizumab (OCR) et grossesses : actualisation des données. Revue Neurologique. 2021 Apr 1; 177:s106. Bove BR, Oreja-Guevara OC, Hellwig HK, Buffels BR, Pasquarelli PN, Zecevic ZD, Vukusic VS. .
      View in: Publisher Site   Mentions:
    97. Effects of COVID-19 "Sheltering in Place" on Activity in People With Multiple Sclerosis. Neurol Clin Pract. 2021 Apr; 11(2):e216-e218. Block VJ, Bove R, Gelfand JM, Cree BAC. PMID: 33842099; PMCID: PMC8032435.
      View in: PubMed   Mentions: 4  
    98. Treatment of Women with Multiple Sclerosis Planning Pregnancy. Curr Treat Options Neurol. 2021; 23(4):11. Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K. PMID: 33814892; PMCID: PMC8008016.
      View in: PubMed   Mentions: 24  
    99. Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review. Front Neurol. 2021; 12:554375. Bove R, Okai A, Houtchens M, Elias-Hamp B, Lugaresi A, Hellwig K, Kubala Havrdová E. PMID: 33815241; PMCID: PMC8017266.
      View in: PubMed   Mentions: 10  
    100. Effects of Transcranial Direct Current Stimulation on Cognition, Mood, Pain, and Fatigue in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Front Neurol. 2021; 12:626113. Hsu WY, Cheng CH, Zanto TP, Gazzaley A, Bove RM. PMID: 33763014; PMCID: PMC7982804.
      View in: PubMed   Mentions: 7  
    101. Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemic. Mult Scler J Exp Transl Clin. 2021 Jan-Mar; 7(1):2055217321997467. McGinley MP, Gales S, Rowles W, Wang Z, Hsu WY, Amezcua L, Bove R. PMID: 33738110; PMCID: PMC7934057.
      View in: PubMed   Mentions: 7  
    102. Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS. Neurol Neuroimmunol Neuroinflamm. 2021 03; 8(2). Anderson A, Krysko KM, Rutatangwa A, Krishnakumar T, Chen C, Rowles W, Zhao C, Houtchens MK, Bove R. PMID: 33608303; PMCID: PMC8105896.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    103. CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study. Mult Scler J Exp Transl Clin. 2021 Jan-Mar; 7(1):2055217321988937. Block VJ, Gopal A, Rowles W, -Yueh C, Gelfand JM, Bove R. PMID: 33796329; PMCID: PMC7970691.
      View in: PubMed   Mentions: 4  
    104. Application of an Adaptive, Digital, Game-Based Approach for Cognitive Assessment in Multiple Sclerosis: Observational Study. J Med Internet Res. 2021 01 20; 23(1):e24356. Hsu WY, Rowles W, Anguera JA, Zhao C, Anderson A, Alexander A, Sacco S, Henry R, Gazzaley A, Bove R. PMID: 33470940; PMCID: PMC7840186.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021 01 23; 397(10271):334-346. Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, Dean J, DeBiasi R, Desai J, Elrick MJ, Farias-Moeller R, Gombolay GY, Greenberg B, Harmelink M, Hong S, Hopkins SE, Oleszek J, Otten C, Sadowsky CL, Schreiner TL, Thakur KT, Van Haren K, Carballo CM, Chong PF, Fall A, Gowda VK, Helfferich J, Kira R, Lim M, Lopez EL, Wells EM, Yeh EA, Pardo CA, AFM working group. PMID: 33357469; PMCID: PMC7909727.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    106. Underutilization of physical therapy for symptomatic women with MS during and following pregnancy. Mult Scler Relat Disord. 2021 Feb; 48:102703. Block VJ, Mestas O, Anderson A, Singh J, Wylie L, Guo CY, Green AJ, Gelfand JM, Bove R. PMID: 33387862.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis. Mult Scler. 2021 08; 27(9):1432-1441. Romeo AR, Rowles WM, Schleimer ES, Barba P, Hsu WY, Gomez R, Santaniello A, Zhao C, Pearce JR, Jones JB, Cree BC, Hauser SL, Gelfand JM, Stewart WF, Goodin DS, Bove RM. PMID: 33236967; PMCID: PMC8144241.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    108. Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS. AJNR Am J Neuroradiol. 2020 12; 41(12):2219-2226. Sacco S, Caverzasi E, Papinutto N, Cordano C, Bischof A, Gundel T, Cheng S, Asteggiano C, Kirkish G, Mallott J, Stern WA, Bastianello S, Bove RM, Gelfand JM, Goodin DS, Green AJ, Waubant E, Wilson MR, Zamvil SS, Cree BA, Hauser SL, Henry RG, University of California, San Francisco MS-EPIC Team. PMID: 33154077; PMCID: PMC7963254.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    109. Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study. NPJ Digit Med. 2020; 3:135. Zhao Y, Wang T, Bove R, Cree B, Henry R, Lokhande H, Polgar-Turcsanyi M, Anderson M, Bakshi R, Weiner HL, Chitnis T, SUMMIT Investigators. PMID: 33083570; PMCID: PMC7567781.
      View in: PubMed   Mentions: 15  
    110. Electronic health record technology designed for the clinical encounter: MS neuroSHARE. Neurology Clinical Practice. 2020 Oct 6; 10.1212/cpj.0000000000000986. Bove BR, Bruce BC, Lunders LC, Pearce PJ, Liu LJ, Schleimer SE, Hauser HS, Stewart SW, Jones JJ. .
      View in: Publisher Site   Mentions:
    111. Effects of COVID-19 “Sheltering in Place” on Activity in People with Multiple Sclerosis. Neurology Clinical Practice. 2020 Sep 28; 10.1212/cpj.0000000000000982. Block BV, Bove BR, Gelfand GJ, Cree CB. .
      View in: Publisher Site   Mentions:
    112. MRI activity in MS and completed pregnancy: Data from a tertiary academic center. Neurol Neuroimmunol Neuroinflamm. 2020 11 05; 7(6). Houtchens M, Bove R, Healy B, Houtchens S, Kaplan TB, Mahlanza T, Chitnis T, Bakshi R. PMID: 32917773; PMCID: PMC7643615.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    113. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A. 2020 09 15; 117(37):22932-22943. Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, University of California, San Francisco MS-EPIC Team, Guo CY, Green AJ, Bove RM, DeRisi JL, Gelfand JM, Cree BAC, Zamvil SS, Baranzini SE, Hauser SL, Wilson MR. PMID: 32859762; PMCID: PMC7502747.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    114. A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. J Med Internet Res. 2020 07 06; 22(7):e15605. Schleimer E, Pearce J, Barnecut A, Rowles W, Lizee A, Klein A, Block VJ, Santaniello A, Renschen A, Gomez R, Keshavan A, Gelfand JM, Henry RG, Hauser SL, Bove R. PMID: 32628124; PMCID: PMC7381029.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    115. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord. 2020; 13:1756286420936166. Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. PMID: 32655689; PMCID: PMC7331774.
      View in: PubMed   Mentions: 27  
    116. A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study. Mult Scler. 2021 04; 27(5):778-789. Bove R, Rowles W, Zhao C, Anderson A, Friedman S, Langdon D, Alexander A, Sacco S, Henry R, Gazzaley A, Feinstein A, Anguera JA. PMID: 32584155.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    117. We should monitor our patients with wearable technology instead of neurological examination - Yes. Mult Scler. 2020 08; 26(9):1024-1026. Block VJ, Bove R. PMID: 32755299.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    118. Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4). LaHue SC, Anderson A, Krysko KM, Rutatangwa A, Dorsey MJ, Hale T, Mahadevan U, Rogers EE, Rosenstein MG, Bove R. PMID: 32461351; PMCID: PMC7286664.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    119. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy. J Neuroimaging. 2020 05; 30(3):251-266. Bagnato F, Gauthier SA, Laule C, Moore GRW, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA, Öz G, Rooney WD, Smith SA, Calabresi PA, Henry RG, Oh J, Ontaneda D, Pelletier D, Reich DS, Shinohara RT, Sicotte NL, NAIMS Cooperative. PMID: 32418324.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    120. Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis. Mult Scler. 2021 01; 27(1):79-89. Mahlanza TD, Manieri MC, Klawiter EC, Solomon AJ, Lathi E, Ionete C, Berriosmorales I, Severson C, Stankiewicz J, Cabot A, Elkort M, Chitnis T, Bove R, Katz J, Houtchens M. PMID: 32065561.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    121. Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis. Mult Scler. 2020 03; 26(3):343-353. Sheehy CK, Bensinger ES, Romeo A, Rani L, Stepien-Bernabe N, Shi B, Helft Z, Putnam N, Cordano C, Gelfand JM, Bove R, Stevenson SB, Green AJ. PMID: 32031464.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    122. Comparison of MS inflammatory activity in women using continuous versus cyclic combined oral contraceptives. Mult Scler Relat Disord. 2020 Jun; 41:101970. Chen CS, Krishnakumar T, Rowles W, Anderson A, Zhao C, Do L, Bove R. PMID: 32088652.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    123. Hypogammaglobulinemia in Patients with Neuromyelitis Optica (NMO). Journal of Allergy and Clinical Immunology. 2020 Feb 1; 145(2):ab215. Tsao TL, Bove BR, Krishnakumar KT, Otani OI. .
      View in: Publisher Site   Mentions:
    124. Neuroimaging and radiation exposure in pregnancy. Handb Clin Neurol. 2020; 171:179-191. Anderson A, Singh J, Bove R. PMID: 32736749.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    125. Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update. Neurology. 2020 01 07; 94(1):30-38. Hatcher-Martin JM, Adams JL, Anderson ER, Bove R, Burrus TM, Chehrenama M, Dolan O'Brien M, Eliashiv DS, Erten-Lyons D, Giesser BS, Moo LR, Narayanaswami P, Rossi MA, Soni M, Tariq N, Tsao JW, Vargas BB, Vota SA, Wessels SR, Planalp H, Govindarajan R. PMID: 31801829.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    126. Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions. Neurol Neuroimmunol Neuroinflamm. 2020 01; 7(1). Krysko KM, LaHue SC, Anderson A, Rutatangwa A, Rowles W, Schubert RD, Marcus J, Riley CS, Bevan C, Hale TW, Bove R. PMID: 31719115; PMCID: PMC6857908.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    127. Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years. JAMA Neurol. 2019 Nov 01; 76(11):1359-1366. Cantó E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, Häring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, Benkert P, Oksenberg JR, Kuhle J. PMID: 31403661; PMCID: PMC6692664.
      View in: PubMed   Mentions: 68     Fields:    
    128. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med. 2019 11; 25(11):1748-1752. Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GM, Sample HA, Zorn KC, Banerji D, Khan LM, Bove R, Hauser SL, Gelfand AA, Johnson-Kerner BL, Nash K, Krishnamoorthy KS, Chitnis T, Ding JZ, McMillan HJ, Chiu CY, Briggs B, Glaser CA, Yen C, Chu V, Wadford DA, Dominguez SR, Ng TFF, Marine RL, Lopez AS, Nix WA, Soldatos A, Gorman MP, Benson L, Messacar K, Konopka-Anstadt JL, Oberste MS, DeRisi JL, Wilson MR. PMID: 31636453; PMCID: PMC6858576.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    129. Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good? Neurology. 2019 10 08; 93(15):668-672. LaHue SC, Gelfand AA, Bove RM. PMID: 31492717.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    130. Unmet Needs in the Evaluation, Treatment, and Recovery for 167 Children Affected by Acute Flaccid Myelitis Reported by Parents Through Social Media. Pediatr Neurol. 2020 01; 102:20-27. Bove R, Rowles W, Carleton M, Olivera E, Sheehan M, Werdal HP, Scott R, Axton L, Benson L. PMID: 31630913.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    131. Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis. Mult Scler. 2020 10; 26(11):1410-1419. Bove R, Rankin K, Lin C, Zhao C, Correale J, Hellwig K, Michel L, Laplaud DA, Chitnis T. PMID: 31368394.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    132. A Natural Language Algorithm Identifies Multiple Sclerosis Relapses from Clinical Notes With High Sensitivity (P3.2-002). Neurology. 2019 Apr 9; 92(15_supplement). Krishnakumar KT, Chen CC, Damotte DV, Schleimer SE, Santaniello SA, Gelfand GJ, Lizee LA, Gourraud GP, Hollenbach HJ, Bove BR. .
      View in: Publisher Site   Mentions:
    133. Global Teleneurology Service: First Insights (P2.6-045). Neurology. 2019 Apr 9; 92(15_supplement). Bove BR, Arias AJ, Barnecut BA, Branagan BL, Chow CF, Gelfand GJ, Josephson JS, Katz KM, Lomen-Hoerth LC, Schleimer SE, Singhal SN, Wilson WM, Niyongabo NT, Norwood NA, Kaneza KC, Kohnen KE, Christensen CC, Van Leeuwen VJ. .
      View in: Publisher Site   Mentions:
    134. Ocrelizumab Treatment Effect on Upper Limb Function in PPMS Patients with Disability: Subgroup Results of the ORATORIO Study to Inform the ORATORIO-HAND Study Design (P3.2-091). Neurology. 2019 Apr 9; 92(15_supplement). Giovannoni GG, Airas AL, Bove BR, Boyko BA, Cutter CG, Hobart HJ, Kuhle KJ, Oh OJ, Tur TC, Garas GM, Model MF, Manfrini MM, Wolinsky WJ. .
      View in: Publisher Site   Mentions:
    135. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol. 2019 05; 85(5):653-666. University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. PMID: 30851128; PMCID: PMC6518998.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    136. Social Media in the Age of the "New Polio". N Engl J Med. 2019 Mar 28; 380(13):1195-1197. Bove R. PMID: 30917256.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    137. Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis. JAMA Netw Open. 2019 03 01; 2(3):e190570. Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM. PMID: 30874777; PMCID: PMC6484622.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    138. Hypogammaglobulinemia in Multiple Sclerosis Patients Receiving Disease-Modifying Immunomodulatory Agents. Journal of Allergy and Clinical Immunology. 2019 Feb 1; 143(2):ab16. Tsao TL, Otani OI, Bove BR. .
      View in: Publisher Site   Mentions:
    139. A Parental Perspective on Strengthening Knowledge After Acute Flaccid Myelitis. JAMA Pediatr. 2019 Feb 01; 173(2):127. Bove R, Werdal H, Olivera E. PMID: 30500055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    140. Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors. J Neurosci. 2019 03 20; 39(12):2184-2194. Rankin KA, Mei F, Kim K, Shen YA, Mayoral SR, Desponts C, Lorrain DS, Green AJ, Baranzini SE, Chan JR, Bove R. PMID: 30696729; PMCID: PMC6433770.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    141. Demyelinating Disease and Pregnancy. Neurology and Psychiatry of Women. 2019 Jan 1; 145-156. Kaplan KT, Bove BR. .
      View in: Publisher Site   Mentions:
    142. Effect of pregnancy loss on MS disease activity. J Neurol Sci. 2019 Feb 15; 397:58-60. Kaplan TB, Bove R, Galetta K, Healy B, Chitnis C, Houtchens M. PMID: 30590343.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    143. A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study. Neurol Ther. 2019 Jun; 8(1):135-145. Bove RM, Rush G, Zhao C, Rowles W, Garcha P, Morrissey J, Schembri A, Alailima T, Langdon D, Possin K, Gazzaley A, Feinstein A, Anguera J. PMID: 30506301; PMCID: PMC6534643.
      View in: PubMed   Mentions: 18  
    144. Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation. Curr Treat Options Neurol. 2018 Oct 22; 20(12):53. Sokolov AA, Grivaz P, Bove R. PMID: 30345468.
      View in: PubMed   Mentions: 13  
    145. We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Commentary. Mult Scler. 2019 02; 25(2):190-192. Bove R. PMID: 30346219.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e505. Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM. PMID: 30775409; PMCID: PMC6354660.
      View in: PubMed   Mentions: 20     Fields:    
    147. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Mult Scler. 2019 10; 25(11):1526-1534. Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM. PMID: 30141729.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    148. Reproductive period and epigenetic modifications of the oxidative phosphorylation pathway in the human prefrontal cortex. PLoS One. 2018; 13(7):e0199073. Bove RM, Patrick E, Aubin CM, Srivastava G, Schneider JA, Bennett DA, De Jager PL, Chibnik LB. PMID: 30052629; PMCID: PMC6063396.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    149. A case for gender-based approach to multiple sclerosis therapeutics. Front Neuroendocrinol. 2018 07; 50:123-134. Houtchens MK, Bove R. PMID: 30040969.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    150. Caring for Women with Multiple Sclerosis Across the Lifespan. Curr Neurol Neurosci Rep. 2018 05 23; 18(7):36. Rankin K, Bove R. PMID: 29789964.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    151. Continuous Wrist-Worn Accelerometry Captures Change in Average Daily Step Count in People with Multiple Sclerosis Over One Year (N5.001). Neurology. 2018 Apr 10; 90(15_supplement). Block BV, Bove BR, Keshavan KA, Zhao ZC, Bevan BC, Crabtree-Hartman CE, Graves GJ, Green GA, Pletcher PM, Olgin OJ, Marcus MG, Allen AD, Cree CB, Gelfand GJ. .
      View in: Publisher Site   Mentions:
    152. Assisted Reproductive Technologies and Multiple Sclerosis Relapses: A New Case Series, and Pooled Analyses of Existing Studies. (P4.366). Neurology. 2018 Apr 10; 90(15_supplement). Rankin RK, Zhao ZC, Correale CJ, Hellwig HK, Michel ML, Laplaud LD, Chitnis CT, Bove BR. .
      View in: Publisher Site   Mentions:
    153. Effect of Pregnancy Loss on MS Disease Activity (P4.370). Neurology. 2018 Apr 10; 90(15_supplement). Kaplan KT, Bove BR, Galetta GK, Healy HB, Chitnis CT, Houtchens HM. .
      View in: Publisher Site   Mentions:
    154. Telemedicine Reduces Barriers to Care for Patients with Multiple Sclerosis and Neuroinflammation (P4.378). Neurology. 2018 Apr 10; 90(15_supplement). Bove BR, Garcha GP, Bevan BC, Crabtree-Hartman CE, Green GA, Gelfand GJ. .
      View in: Publisher Site   Mentions:
    155. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm. 2018 May; 5(3):e453. Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. PMID: 29564373; PMCID: PMC5858951.
      View in: PubMed   Mentions: 64     Fields:    
    156. Why monkeys do not get multiple sclerosis (spontaneously): An evolutionary approach. Evol Med Public Health. 2018; 2018(1):43-59. Bove RM. PMID: 29492266; PMCID: PMC5824939.
      View in: PubMed   Mentions: 8  
    157. Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients. Mult Scler. 2019 03; 25(3):344-351. Bove R, Healy BC, Musallam A, Soltany P, Diaz-Cruz C, Sattarnezhad N, Glanz BI, Kivisäkk P, Miller KK, Chitnis T. PMID: 29320952; PMCID: PMC6026579.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    158. Harnessing electronic medical records to advance research on multiple sclerosis. Mult Scler. 2019 03; 25(3):408-418. Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA. PMID: 29310490.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    159. Hormones and MS: Risk factors, biomarkers, and therapeutic targets. Mult Scler. 2018 01; 24(1):17-21. Bove R, Gilmore W. PMID: 29307303.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    160. Diagnosing multiple sclerosis: art and science. Lancet Neurol. 2018 02; 17(2):109-111. Bove RM, Hauser SL. PMID: 29275980.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    161. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology. 2017 Nov 28; 89(22):2238-2244. Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, Paul F, Cross AH, Jacobs A, Chitnis T, Weinshenker B. PMID: 29093070; PMCID: PMC5705247.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    162. Remyelinating Pharmacotherapies in Multiple Sclerosis. Neurotherapeutics. 2017 Oct; 14(4):894-904. Bove RM, Green AJ. PMID: 28948533; PMCID: PMC5722779.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    163. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Mult Scler. 2018 10; 24(11):1485-1498. Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL, SUMMIT Consortium. PMID: 28847219; PMCID: PMC5821573.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    164. Atrophy of spinal cord gray matter is detectable at an early stage of multiple sclerosis (S2.003). Neurology. 2017 Apr 18; 88(16_supplement). Schlaeger SR, Papinutto PN, Zhu ZA, Datta DE, Bevan BC, Caverzasi CE, Jordan JK, Lobach LI, Keshavan KA, Kirkish KG, Stern SW, Devereux DM, Baker BN, Bove BR, Gelfand GJ, Graves GJ, Green GA, Waubant WE, Wilson WM, Goodin GD, Cree CB, Hauser HS, Henry HR. .
      View in: Publisher Site   Mentions:
    165. Towards a telemedicine-derived disability scale in multiple sclerosis (P3.369). Neurology. 2017 Apr 18; 88(16_supplement). Bove BR, Garcha GP, Bevan BC, Crabtree-Hartman CE, Wallin WM, Green GA, Gelfand GJ. .
      View in: Publisher Site   Mentions:
    166. Continuous Daily Assessment Of Multiple Sclerosis Disability Using Remote Step Count Monitoring (P1.376). Neurology. 2017 Apr 18; 88(16_supplement). Block BV, Lizee LA, Crabtree-Hartman CE, Bevan BC, Graves GJ, Bove BR, Green GA, Nourbakhsh NB, Tremblay TM, Gourraud GP, Ng NM, Pletcher PM, Olgin OJ, Marcus MG, Allen AD, Cree CB, Gelfand GJ. .
      View in: Publisher Site   Mentions:
    167. pRNFL as a predictor of medium/long term disability in MS patients (P6.031). Neurology. 2017 Apr 18; 88(16_supplement). Cordano CC, Damotte DV, Devereux DM, Baker BN, Bove BR, Bevan BC, Crabtree-Hartman CL, Cree CB, Goodin GD, Graves GJ, Hollenbach HJ, Hauser HS, Henry HR, Gourraud GP, Gelfand GJ, Green GA. .
      View in: Publisher Site   Mentions:
    168. A high-throughput screen identifies a candidate molecule that promotes remyelination with significant translational potential (S50.003). Neurology. 2017 Apr 18; 88(16_supplement). Rankin RK, Shen SY, Mei MF, Desponts DC, Lorrain LD, Green GA, Chan CJ, Bove BR. .
      View in: Publisher Site   Mentions:
    169. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e339. Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, Weinshenker B, Jacob A, Klawiter EC, Chitnis T. PMID: 28382320; PMCID: PMC5366671.
      View in: PubMed   Mentions: 19     Fields:    
    170. Oral contraceptives and MS disease activity in a contemporary real-world cohort. Mult Scler. 2018 02; 24(2):227-230. Bove R, Rankin K, Chua AS, Saraceno T, Sattarnezhad N, Greeke E, Stuart F, LaRussa A, Glanz BI, Chitnis T. PMID: 28155573.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    171. Menopause and Multiple Sclerosis. Health Issues in Women with Multiple Sclerosis. 2017 Jan 1; 85-96. Bove BR. .
      View in: Publisher Site   Mentions:
    172. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. J Neurol. 2017 Feb; 264(2):316-326. Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM. PMID: 27896433; PMCID: PMC5292081.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    173. Immunology of neuromyelitis optica during pregnancy. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3(6):e288. Davoudi V, Keyhanian K, Bove RM, Chitnis T. PMID: 27761482; PMCID: PMC5056648.
      View in: PubMed   Mentions: 22     Fields:    
    174. Patient Management Problem-Preferred Responses. Continuum (Minneap Minn). 2016 Oct; 22(5, Neuroimaging):1738-1746. Bove R. PMID: 27741002.
      View in: PubMed   Mentions:    Fields:    
    175. Patient Management Problem. Continuum (Minneap Minn). 2016 Oct; 22(5, Neuroimaging):1731-1737. Bove R. PMID: 27741001.
      View in: PubMed   Mentions:    Fields:    
    176. Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis. Neurology. 2016 Oct 04; 87(14):1457-1463. Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL. PMID: 27605175; PMCID: PMC5075979.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    177. Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset. Neurol Genet. 2016 Aug; 2(4):e88. Bove R, Chua AS, Xia Z, Chibnik L, De Jager PL, Chitnis T. PMID: 27504495; PMCID: PMC4962522.
      View in: PubMed   Mentions: 10  
    178. Women's experiences of menopause in an online MS cohort: A case series. Mult Scler Relat Disord. 2016 Sep; 9:56-9. Bove R, Vaughan T, Chitnis T, Wicks P, De Jager PL. PMID: 27645345; PMCID: PMC5031240.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    179. Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity. Mult Scler Relat Disord. 2016 Jul; 8:136-40. Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T. PMID: 27456889.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    180. Women's Issues in Multiple Sclerosis. Semin Neurol. 2016 Apr; 36(2):154-62. Bove R. PMID: 27116722.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    181. Hormone Therapy Use and Physical Quality of Life in Postmenopausal Women with Multiple Sclerosis (I5.007). Neurology. 2016 Apr 5; 86(16_supplement). Bove BR, White WC, Fitzgerald FK, Chitnis CT, Chibnik CL, Ascherio AA, Munger MK. .
      View in: Publisher Site   Mentions:
    182. Hormone Therapy Use and Physical Quality of Life in Postmenopausal Women with Multiple Sclerosis (P3.040). Neurology. 2016 Apr 5; 86(16_supplement). Bove BR, White WC, Fitzgerald FK, Chitnis CT, Chibnik CL, Ascherio AA, Munger MK. .
      View in: Publisher Site   Mentions:
    183. Hormonal Exposures Relate to Clinical Phenotype in Women with Neuromyelitis Optica (S12.005). Neurology. 2016 Apr 5; 86(16_supplement). Bove BR, Elsone EL, Alvarez AE, Borisow BN, Cortez CM, Mateen MF, Mealy MM, Sorum SJ, Mutch MK, Tobyne TS, Ruprecht RK, Buckle BG, Levy LM, Wingerchuk WD, Friedemann FP, Cross CA, Weinshenker WB, Jacob JA, Klawiter KE, Chitnis CT. .
      View in: Publisher Site   Mentions:
    184. Association between adiposity and cognitive function in young men: Hormonal mechanisms. Obesity (Silver Spring). 2016 Apr; 24(4):954-61. Bove RM, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK. PMID: 26880680; PMCID: PMC4814338.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    185. Effect of growth hormone on cognitive function in young women with abdominal obesity. Clin Endocrinol (Oxf). 2016 Apr; 84(4):635-7. Bove RM, White CC, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK. PMID: 26663235; PMCID: PMC4789146.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. Multiple sclerosis in men: management considerations. J Neurol. 2016 Jul; 263(7):1263-73. Bove R, McHenry A, Hellwig K, Houtchens M, Razaz N, Smyth P, Tremlett H, Sadovnick AD, Rintell D. PMID: 26725085.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    187. Management of Multiple Sclerosis During Pregnancy and the Reproductive Years. Obstetric Anesthesia Digest. 2015 Dec 1; 35(4):186-187. Bove BR, Alwan AS, Friedman FJ, Hellwig HK, Houtchens HM, Koren KG, Lu LE, McElrath MT, Smyth SP, Tremlett TH, Sadovnick SA. .
      View in: Publisher Site   Mentions:
    188. Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2015 Dec; 2(6):e162. Bove R, White CC, Giovannoni G, Glanz B, Golubchikov V, Hujol J, Jennings C, Langdon D, Lee M, Legedza A, Paskavitz J, Prasad S, Richert J, Robbins A, Roberts S, Weiner H, Ramachandran R, Botfield M, De Jager PL. PMID: 26516627; PMCID: PMC4608760.
      View in: PubMed   Mentions: 29     Fields:    
    189. Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Mult Scler. 2016 06; 22(7):935-43. Bove R, Healy BC, Musallam A, Glanz BI, De Jager PL, Chitnis T. PMID: 26447063; PMCID: PMC4824677.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    190. The role of hormones and gender in MS. Journal of the Neurological Sciences. 2015 Oct 1; 357:e472. Sadovnick SD, Bove BR, Chitnis CT. .
      View in: Publisher Site   Mentions:
    191. The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS. Neurology. 2015 Oct 06; 85(14):1209-13. Bove R, Malik MT, Diaz-Cruz C, Chua A, Saraceno TJ, Bargiela D, Greeke E, Glanz BI, Healy BC, Chitnis T. PMID: 26341868; PMCID: PMC4607599.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    192. Evaluation of the revised 2013 MS clinical course definitions in the CLIMB real world cohort (P5.190). Neurology. 2015 Apr 6; 84(14_supplement). Chitnis CT, Healy HB, Glanz GB, Bakshi BR, Bove BR, De Jager DP, Houtchens HM, Kimbrough KD, Severson SC, Stankiewicz SJ, Stazzone SL, Weiner WH. .
      View in: Publisher Site   Mentions:
    193. Association between low testosterone and brain atrophy in men multiple sclerosis. (S38.006). Neurology. 2015 Apr 6; 84(14_supplement). Bove BR, Healy HB, Egorova ES, Glanz GB, Bakshi BR, De Jager DP, Miller MK, Guttmann GC, Chitnis CT. .
      View in: Publisher Site   Mentions:
    194. The male 2D:4D digit ratio: a proxy for prenatal androgen exposure and a risk biomarker for multiple sclerosis. (S38.005). Neurology. 2015 Apr 6; 84(14_supplement). Bove BR, Malik MM, Diaz-Cruz DC, Bargiela BD, Chua CA, Saraceno ST, Greeke GE, Glanz GB, Healy HB, Chitnis CT. .
      View in: Publisher Site   Mentions:
    195. Patients report worse MS symptoms after menopause: findings from an online cohort. Mult Scler Relat Disord. 2015 Jan; 4(1):18-24. Bove R, Healy BC, Secor E, Vaughan T, Katic B, Chitnis T, Wicks P, De Jager PL. PMID: 25787049.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    196. Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol. 2014 Dec; 124(6):1157-1168. Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G, Lu E, McElrath TF, Smyth P, Tremlett H, Sadovnick AD. PMID: 25415167.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    197. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport. 2014 Oct 01; 25(14):1156-61. Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, Weiner HL, Ceccarelli A. PMID: 25100554; PMCID: PMC4166046.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    198. Menopause In A Longitudinal Clinical Cohort Of Women With Multiple Sclerosis. (P4.163). Neurology. 2014 Apr 8; 82(10_supplement). Bove BR, Healy HB, Musallam MA, Alsharif AN, Glanz GB, Chitnis CT. .
      View in: Publisher Site   Mentions:
    199. Investigation Of Sex Differences In The Association Between Multiple Sclerosis Disease Severity And Hormonal Markers Of Vitamin D, Obesity, And Testosterone. (S24.003). Neurology. 2014 Apr 8; 82(10_supplement). Bove BR, Musallam MA, Healy HB, Soltany SP, Kivisakk KP, Glanz GB, De Jager DP, Miller MK, Chitnis CT. .
      View in: Publisher Site   Mentions:
    200. Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler. 2014 Oct; 20(12):1584-92. Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T. PMID: 24710799; PMCID: PMC4188801.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    201. The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler. 2014 Apr; 20(5):520-6. Bove R, Chitnis T. PMID: 24561324.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    202. Patient management problem. Continuum (Minneap Minn). 2014 Feb; 20(1 Neurology of Pregnancy):230-4, 235-44. Bove RM. PMID: 24492825; PMCID: PMC10564053.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    203. Neuroradiology in women of childbearing age. Continuum (Minneap Minn). 2014 Feb; 20(1 Neurology of Pregnancy):23-41. Bove RM, Klein JP. PMID: 24492809; PMCID: PMC10564062.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    204. Dedication to Autumn Klein, MD, PhD (1971–2013). CONTINUUM Lifelong Learning in Neurology. 2014 Feb 1; 20(1):19-20. Feske FS, Bove BR. .
      View in: Publisher Site   Mentions:
    205. Patient Management Problem-Preferred Responses. CONTINUUM Lifelong Learning in Neurology. 2014 Feb 1; 20(1):235-244. Bove BR. .
      View in: Publisher Site   Mentions:
    206. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014 Jan 21; 82(3):222-9. Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, De Jager PL. PMID: 24336141; PMCID: PMC3902759.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    207. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. BMC Neurol. 2013 Nov 11; 13:172. Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. PMID: 24215402; PMCID: PMC3829106.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    208. Modeling disease severity in multiple sclerosis using electronic health records. PLoS One. 2013; 8(11):e78927. Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, Shaw SY, Ananthakrishnan AN, Szolovits P, Weiner HL, Karlson EW, Murphy SN, Savova GK, Cai T, Churchill SE, Plenge RM, Kohane IS, De Jager PL. PMID: 24244385; PMCID: PMC3823928.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    209. Menopause in multiple sclerosis: therapeutic considerations. J Neurol. 2014 Jul; 261(7):1257-68. Bove R, Chitnis T, Houtchens M. PMID: 24101131.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    210. No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. BMC Neurol. 2013 Jul 03; 13:73. Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S, Guttmann CR, De Jager PL, Chitnis T. PMID: 23822612; PMCID: PMC3707791.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    211. Metabolic and endocrine correlates of cognitive function in healthy young women. Obesity (Silver Spring). 2013 Jul; 21(7):1343-9. Bove RM, Brick DJ, Healy BC, Mancuso SM, Gerweck AV, Bredella MA, Sherman JC, Miller KK. PMID: 23671055; PMCID: PMC3742554.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    212. Sexual disparities in the incidence and course of MS. Clin Immunol. 2013 Nov; 149(2):201-10. Bove R, Chitnis T. PMID: 23608496.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    213. Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course. PLoS One. 2013; 8(3):e59707. Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, De Jager PL. PMID: 23527256; PMCID: PMC3603866.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    214. Polygyny and women's health in rural Mali. J Biosoc Sci. 2014 Jan; 46(1):66-89. Bove RM, Vala-Haynes E, Valeggia C. PMID: 23480408; PMCID: PMC3855884.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    215. Autoimmune diseases and reproductive aging. Clin Immunol. 2013 Nov; 149(2):251-64. Bove R. PMID: 23522436; PMCID: PMC3805815.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    216. Hormonal Associations in the Early Disease Course in Men with Relapsing Remitting Multiple Sclerosis (IN8-2.003). Neurology. 2013 Feb 12; 80(7_supplement). Bove BR, Musallam MA, Healy HB, Raghavan RK, Khoury KS, Weiner WH, De Jager DP, Miller MK, Chitnis CT. .
      View in: Publisher Site   Mentions:
    217. Early Surgical Menopause Is Associated with a Spectrum of Cognitive Decline (S24.003). Neurology. 2013 Feb 12; 80(7_supplement). Bove BR, Secor SE, Chibnik CL, Barnes BL, Schneider SJ, Bennett BD, De Jager DP. .
      View in: Publisher Site   Mentions:
    218. Hormonal Associations in the Early Disease Course in Men with Relapsing Remitting Multiple Sclerosis (P02.128). Neurology. 2013 Feb 12; 80(7_supplement). Bove BR, Musallam MA, Healy HB, Raghavan RK, Khoury KS, Weiner WH, De Jager DP, Miller MK, Chitnis CT. .
      View in: Publisher Site   Mentions:
    219. High Risk of Initial Symptom Onset Post-Partum in Neuromyelitis Optica (S60.001). Neurology. 2013 Feb 12; 80(7_supplement). Klawiter KE, Alvarez AE, Elsone EL, Mateen MF, Borisow BN, Bove BR, Sorum SJ, Mutch MK, Tobyne TS, Musallam MA, Ruprecht RK, Buckle BG, Paul PF, Levy LM, Cross CA, Jacob JA, Chitnis CT, Weinshenker WB. .
      View in: Publisher Site   Mentions:
    220. Early Surgical Menopause Is Associated with a Spectrum of Cognitive Decline (IN8-2.004). Neurology. 2013 Feb 12; 80(7_supplement). Bove BR, Secor SE, Chibnik CL, Barnes BL, Schneider SJ, Bennett BD, De Jager DP. .
      View in: Publisher Site   Mentions:
    221. The pattern and pace of hyperacute hemorrhage expansion. Neurocrit Care. 2012 Oct; 17(2):250-4. Edlow BL, Bove RM, Viswanathan A, Greenberg SM, Silverman SB. PMID: 22826138; PMCID: PMC3552298.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    222. Relapsing course of immunoglobulin G4-related pachymeningitis. Neurology. 2012 Aug 07; 79(6):604-6. Shapiro KA, Bové RM, Volpicelli ER, Mallery RM, Stone JH. PMID: 22843267.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    223. Women's health in urban Mali: social predictors and health itineraries. Soc Sci Med. 2012 Oct; 75(8):1392-9. Bove RM, Vala-Haynes E, Valeggia CR. PMID: 22818488; PMCID: PMC3560408.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    224. Effect of gender on late-onset multiple sclerosis. Mult Scler. 2012 Oct; 18(10):1472-9. Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T. PMID: 22383227.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    225. My moment. Ann Intern Med. 2010 Aug 17; 153(4):270-1. Bove RM. PMID: 20713795.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    226. Polygyny and women's health in sub-Saharan Africa. Soc Sci Med. 2009 Jan; 68(1):21-9. Bove R, Valeggia C. PMID: 18952335.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    227. Of snakes and men: the evolution of ACE inhibitors. J Renin Angiotensin Aldosterone Syst. 2007 Mar; 8(1):1-2. Bomback AS, Bove RM, Klemmer PJ. PMID: 17487820.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    228. Deck of Cards. Journal of Surgical Education. 2006 Nov 1; 63(6):482. Bove BR. .
      View in: Publisher Site   Mentions:
    229. Nondiagnosed uveal melanomas. Ophthalmology. 2004 Mar; 111(3):554-7. Bove R, Char DH. PMID: 15019335.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    230. Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments. Am J Ophthalmol. 2003 Jul; 136(1):180-2. Char DH, Bove R, Phillips TL. PMID: 12834689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    231. Girl helpers and time allocation of nursing women among the Toba of Argentina. Hum Nat. 2002 Dec; 13(4):457-72. Bove RB, Valeggia CR, Ellison PT. PMID: 26193090.
      View in: PubMed   Mentions: 12     Fields:    
    232. 20 MHz high frequency ultrasound assessment of scleral and intraocular conjunctival squamous cell carcinoma. Br J Ophthalmol. 2002 Jun; 86(6):632-5. Char DH, Kundert G, Bove R, Crawford JB. PMID: 12034684; PMCID: PMC1771173.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Riley's Networks
    Concepts (372)
    Derived automatically from this person's publications.
    _
    Co-Authors (109)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _